Methods for treating multiple myeloma

NZ836983APending Publication Date: 2026-09-25JANSSEN BIOTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ836983
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-05-12
Filing Date
2021-09-16
Publication Date
2026-09-25

Smart Images

  • Figure 1_ABST
    Figure 1_ABST
Patent Text Reader

Abstract

Methods of treating a hematological malignancy using a GPRC5DxCD3 bispecific antibody are described. The hematological malignancy can be a relapsed or refractory multiple myeloma, and the GPRC5DxCD3 bispecific antibody can be talquetamab.
Need to check novelty before this filing date? Find Prior Art